[Other] Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial |
|
This post will be closed automatically in 2026-10-25 17:14
Best Answer
7 day(s) ago
|
| |
20
[Single chapter]I need the chapter ※The History of Earth and Life§ from the Portuguese student textbook
20
Low-Bandwidth Fixed-Trim Control of a Guided Projectile
10
Environmental remediation of acid mine drainage: an overview of potential phytoremediation with Phragmites australis
10
Molecular and tissue regulation of memory B cells
50
Kinetics of Adsorption on Carbon from Solution
